MedTrace Logo

Role of Hyoscine Bromide in Latent and Active Labor

NCT02103166 · Status: SUSPENDED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 180

Last updated 2016-08-19

No results posted yet for this study

Summary

The purpose of this study is to determine whether hyoscine bromide decreases the duration of the active phase of labor.

Conditions

  • Labor, First Stage

Interventions

DRUG

Hyoscine bromide

20 mg of hyosine bromide diluted in 100 ml of physiological serum (0.9% NaCl).

DRUG

Physiological serum

100 ml of physiological serum (0.9% NaCl).

Sponsors & Collaborators

  • Hospital Clinic of Barcelona

    lead OTHER

Principal Investigators

  • Montse Palacio, MD, PhD · Hospital Clinic of Barcelona

  • Mariona Rius, MD · Hospital Clinic of Barcelona

  • Ana Sandra Hernandez, MD · Hospital Clinic of Barcelona

  • Irene Teixido, MD · Hospital Clinic of Barcelona

  • Irene Vives, MD · Hospital Clinic of Barcelona

  • Midwives Collaborative Group HCP · Hospital Clínic

Study Design

Allocation
RANDOMIZED
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-04-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02103166 on ClinicalTrials.gov